Keyphrases
Pulmonary Hypertension
100%
SOX17
100%
E2F Transcription Factor 1 (E2F1)
100%
Endothelial Cells
27%
Pulmonary Arterial Hypertension
27%
Idiopathic Pulmonary Arterial Hypertension
16%
Lung Epithelial Cells
16%
Pulmonary Microvascular Endothelial Cells (PMVECs)
16%
Knockdown
11%
Transcription Factor
5%
Molecular Mechanism
5%
Genetic Variants
5%
RNA-seq Analysis
5%
Gene-deficient Mice
5%
Luciferase Assay
5%
Congenital Heart Disease
5%
Pharmacological Inhibitors
5%
Genetic Variation
5%
Bone Morphogenetic Protein Signaling
5%
Pulmonary Artery Smooth muscle Cells (PASMCs)
5%
Paracrine Effect
5%
Anti-apoptotic
5%
Single-cell RNA Sequencing (scRNA-seq)
5%
Genetic mutation
5%
Hypoxia-induced Pulmonary Hypertension
5%
Endothelial Dysfunction
5%
Rare Genetic Variants
5%
Hypertension Development
5%
Induced Endothelial Cells
5%
Endothelial Cell Dysfunction
5%
Cellular Junctions
5%
Medicine and Dentistry
Pulmonary Hypertension
100%
Transcription Factor E2F1
100%
Endothelial Cell
83%
Lung
25%
RNA Sequence
16%
Upregulation
8%
Antiapoptotic
8%
Cell Junction
8%
Cell Cycle
8%
Persistent Truncus Arteriosus
8%
Transcription Factors
8%
Signaling Protein
8%
Bone Morphogenetic Protein
8%
Enhancer Region
8%
Hypoxia-Induced Pulmonary Hypertension
8%
Genetic Variation
8%
Endothelial Dysfunction
8%
Luciferase Assay
8%
Arterial Smooth Muscle Cell
8%
Biochemistry, Genetics and Molecular Biology
Transcription Factor E2F1
100%
Genetic Divergence
50%
RNA Sequence
33%
Upregulation
16%
Enhancer Region
16%
Gene Mutation
16%
Transcription Factors
16%
Luciferase
16%
Cell Junction
16%
Cell Cycle
16%
Bone Morphogenetic Protein
16%
Signaling Protein
16%
Genetic Variation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Transcription Factor E2F1
100%
RNA-Sequencing
16%
Antiapoptotic
8%
Transcription Factors
8%
Bone Morphogenetic Protein
8%
Luciferase
8%
Congenital Heart Disease
8%
Endothelial Dysfunction
8%
Hypoxia-Induced Pulmonary Hypertension
8%